Stock Analysts’ Updated EPS Estimates for December 16th (ADP, ALB, ALL, CHH, CTSO, EBS, LIF, LUV, MC, MCHP)

Stock Analysts’ updated eps estimates for Tuesday, December 16th:

Automatic Data Processing (NASDAQ:ADP) had its underperform rating reissued by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a $230.00 target price on the stock, down from their previous target price of $245.00.

Albemarle (NYSE:ALB) was upgraded by analysts at Morgan Stanley from an underweight rating to an equal weight rating. Morgan Stanley currently has $147.00 target price on the stock, up from their previous target price of $58.00.

Allstate (NYSE:ALL) had its equal weight rating reiterated by analysts at Morgan Stanley. The firm currently has a $215.00 price target on the stock, down from their previous price target of $245.00.

Choice Hotels International (NYSE:CHH) had its hold rating reissued by analysts at Argus.

Cytosorbents (NASDAQ:CTSO) had its buy rating reaffirmed by analysts at D. Boral Capital. D. Boral Capital currently has a $10.00 target price on the stock.

Emergent Biosolutions (NYSE:EBS) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $15.00 target price on the stock.

Life360 (NASDAQ:LIF) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $115.00 price target on the stock.

Southwest Airlines (NYSE:LUV) was upgraded by analysts at Barclays PLC from an equal weight rating to an overweight rating. The firm currently has $56.00 target price on the stock, up from their previous target price of $34.00.

Moelis & Company (NYSE:MC) was downgraded by analysts at Keefe, Bruyette & Woods from an outperform rating to a market perform rating. They currently have $80.00 price target on the stock.

Microchip Technology (NASDAQ:MCHP) was upgraded by analysts at Cantor Fitzgerald from a neutral rating to an overweight rating. They currently have $85.00 target price on the stock, up from their previous target price of $65.00.

Microvision (NASDAQ:MVIS) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $3.00 target price on the stock.

NRx Pharmaceuticals (NASDAQ:NRXP) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $40.00 price target on the stock.

Outset Medical (NASDAQ:OM) had its buy rating reaffirmed by analysts at BTIG Research. BTIG Research currently has a $17.00 price target on the stock.

Radiopharm Theranostics (NASDAQ:RADX) had its buy rating reissued by analysts at B. Riley. B. Riley currently has a $16.00 price target on the stock, up from their previous price target of $13.00.

RedCloud (NASDAQ:RCT) had its buy rating reiterated by analysts at Roth Capital. They currently have a $4.50 price target on the stock, down from their previous price target of $5.00.

SolarEdge Technologies (NASDAQ:SEDG) was upgraded by analysts at Morgan Stanley from an underweight rating to an equal weight rating. The firm currently has $33.00 target price on the stock, up from their previous target price of $27.00.

SEI Investments (NASDAQ:SEIC) was upgraded by analysts at Keefe, Bruyette & Woods from a market perform rating to an outperform rating. The firm currently has $97.00 price target on the stock.

Shoals Technologies Group (NASDAQ:SHLS) had its equal weight rating reaffirmed by analysts at Morgan Stanley. Morgan Stanley currently has a $9.50 price target on the stock, down from their previous price target of $11.00.

UBS Group (NYSE:UBS) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating. They currently have $60.30 target price on the stock, up from their previous target price of $44.00.

Upexi (NASDAQ:UPXI) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

DENTSPLY SIRONA (NASDAQ:XRAY) had its outperform rating reissued by analysts at Barrington Research. Barrington Research currently has a $14.00 price target on the stock.

Zscaler (NASDAQ:ZS) was upgraded by analysts at Mizuho from a neutral rating to an outperform rating. They currently have $310.00 target price on the stock.